NeoA reversibly reduces levels of β1 integrin on the cell surface. by Pamela Austin (248283)

“…(C) Immunoblots of whole cell lysates from cells treated with 0, 6.5, or 13 µM of NeoA for 45 min. A representative blot from three independent experiments was probed for β1 integrin (β1) and paxillin (Pax). …”

Relative Energies of α and β Isomers of Keggin Dodecatungstogallate by Karthik M. Sundaram (2652337)

“…The relative energies of β Keggin heteropolytungstates, X<i>ⁿ</i>⁺W₁₂O₄₀^(8-<i>ⁿ</i>^)-, decrease as X<i>ⁿ</i>⁺ is varied within period 3, from P⁵⁺ to Si⁴⁺ to Al³⁺. …”

A model for calculating mRNA dynamics from an RNA-Seq snapshot. by Jesse M. Gray (527662)

“…<p>(<b>A</b>) The decrease in expression from 5′ to 3′ along an intron, shown as the height of the green “guillotine” blade, is a product of the rate of intron synthesis (<i>S</i>) and the time required to transcribe the intron (<i>T</i>_t). …”

Role of systemic corticosteroids in orbital cellulitis: a meta-analysis and literature review by Boo-Young Kim (3709678)

“…Conclusion: Use of systemic steroids as an adjunct to systemic antibiotic therapy for orbital cellulitis may decrease orbital inflammation with a low risk of exacerbating infection. …”

Lack of a Difference between Groups in Plasma HIV-1 RNA during Phase II by Emmanouil Papasavvas (5406)

“…<p>Top panel shows Kaplan-Meyer plot summarizing time to a viral load of more than 5,000 copies/ml in both arms. …”

miR-29a modulates neuronal differentiation of MSCs by targeting REST. by Ping Duan (312653)

“…<p>(A) Lentiviral infection of miR-29a inhibitor decreases miR-29a expression in MSCs. …”

Effects of isobavachalcone treatment on BV-2 cells and Neuro-2a cells. by Haoran Jing (3621779)

“…C: Isobavachalcone decreased microglial-induced neuro-2a death in a co-culture system. …”

Noise levels in each layer of a good and bad noise reducing models. by Suchana Chakravarty (11790671)

“…<p>By increasing (right hand column) and decreasing (left hand column) the level of noise in the input (by changing the kinetics of <i>S</i> synthesis, see below in the <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1009622#pcbi.1009622.s008" target="_blank">S1 Text</a>.) and comparing with the original noisy input (middle column), we show how noise propagating through the pathways for c1-OR (A, B, C), c1c1-minp-FFL (G, H, I), c3-OR (D, E, F), c3c3-minp-FFL (J, K, L), c1i4-mint-FFL (M, N, O), and c3i2-mint-FFL (P, Q, R) networks at mean input = 6. …”

Description of the role of the pharmacist in a multiprofessional team focused on the care of hospitalized elderly by Isabela Vaz Leite Pinto (12817700)

“…A total of 163 pharmaceutical interventions were carried out, representing a mean of 6.79 interventions/patient and 82.2% acceptance. …”

A 10-Year Trend Analysis of Heart Failure in the Less Developed Brazil by Amanda D. F. Fernandes (8618637)

“…Pearson correlation and linear-by-linear association test for trends were calculated, with a level of significance of 5%. Results: From 2008 to 2017, HF admissions decreased 62% (p = 0.004) in Paraiba and 34% (p = 0.004) in Brazil. …”

S7 Fig - by Emily M. Javan (15194865)

“…<p>Expected time until epidemic exceeds 1,000 cumulative infections in a county, assuming (A) Re = 1.5 and (B) 3.0, a 10% case detection rate, and generation time of 6.0 days. …”

Table_1_Blue sky as a protective factor for cardiovascular disease.DOCX by Haosu Tang (13957038)

“…A 10-day increase in annual blue day exposure was associated with a 3% (95% confidence interval [CI]: 1–6%) and 7% (95% CI: 5–10%) decreased risk of fatal or nonfatal CVD and stroke, respectively. …”

Image_2_Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion.pdf by Oliver F. Wirz (11431399)

Image_4_Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion.pdf by Oliver F. Wirz (11431399)

Image_3_Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion.pdf by Oliver F. Wirz (11431399)

Image_1_Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion.pdf by Oliver F. Wirz (11431399)

Figure S1 - Abrogated Inflammatory Response Promotes Neurogenesis in a Murine Model of Japanese Encephalitis by Sulagna Das (228386)

“…</b> Immunoblot showing significantly decreased expression of viral NS3 and NS5 proteins in SVZ of infected mice treated with minocycline (<b>A</b>). …”

Tongue coupling as a therapeutic strategy: electromyographic analysis of different training approaches by Loslene Goulart Souza (12826660)

<i>In-vivo A</i>. <i>baumannii</i> burn wound infection. by Divakara S. S. M. Uppu (705693)

“…<p>(A). Experimental plan. (B). Mice (n = 4) were treated with erythromycin (Ery, 20 mg kg^-1), QCybuAP (50 mg kg ^-1), Q<i>n</i>-prAP (50 mg kg^-1), Q<i>n</i>-prAP + Ery (50 mg kg^-1 + 20 mg kg^-1), QCybuAP + Ery (50 mg kg^-1 + 20 mg kg^-1) and colistin (5 mg kg^-1). …”

Lymphatic density (LD; a) and blood vessel density (BD; b) in the myocardium by Y Ishikawa (46340)

“…The values of BD are 2693.4 ± 197.0 in Normal, 1689.9 ± 640.7 in Stage I, 571.4 ± 478.3 in Stage II, 51.8 ± 30.5 in Stage III, 1430.8 ± 323.1 in Stage IV, 1292.7 ± 153.1 in Stage V, 509.9 ± 276.3 in Stage VI and 130.5 ± 83.8 in Stage VII. …”